ValiRx plc

Corporate Brokers

 Nominated Adviser

Registrars

Solicitors

Auditors

Bankers

Articles of Association

Admission Document

AIM Rule 26

Contact Us

Careers

Strategy & Vision

How we work

Board & Management Team

Collaborative Pipeline

Share price information

Reports & presentations

Regulatory News

Updates

Analyst Research

Partnering & Useful Links

Inaphaea Biolabs

Therapeutic Areas

Evaluation Pipeline

Our Pipeline

Home

DM Sans

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.

ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL. There are no restrictions on the transfer of ValiRx’s shares and these are not listed on any other exchange.

ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, it's “principal” place of business is in the United Kingdom.

: Valirx is subject to the UK City Code on Takeovers and Mergers.

The Total Number of AIM Securities in issue with nominal value of 0.1p is 132,348,673

The information below was last updated on 

The percentage of AIM Securities not in public hands is approximately 23%.

The Board of Directors is committed to applying high standards of corporate governance using the guidance of the QCA Code, revised in April 2018 as devised by the Quoted Companies Alliance.

 sets out ValiRx’s compliance with the ten principles of the QCA Code, displaying how the company complies, and provides links to appropriate disclosures.

These arrangements are also disclosed in our 

These disclosures were last reviewed on the 12-08-2024.